ArticleFrontiers in immunology2021

Glycoprotein Targeted CAR-NK Cells for the Treatment of SARS-CoV-2 Infection.

Ilias Christodoulou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.